Biobank of Research, IRCCS Azienda Opedaliera-Universitaria di Bologna, 40138 Bologna, Italy.
Department of Medical and Surgical Sciences, Bologna University School of Medicine, 40138 Bologna, Italy.
Int J Mol Sci. 2023 Sep 16;24(18):14170. doi: 10.3390/ijms241814170.
Peripheral T-cell lymphomas (PTCLs) are a rare subset of non-Hodgkin lymphomas that often carry significant difficulty in diagnosis and classification because of their rarity and biological complexity. Previous editions of the World Health Organization (WHO) classifications of hemopoietic neoplasms in 2001, 2008, and 2017 aimed to standardize hemopoietic neoplasm diagnosis in general. Since then, crucial clinico-pathological, immunophenotypic, and recent molecular discoveries have been made in the field of lymphomas, contributing to refining diagnostic criteria of several diseases, upgrading entities previously defined as provisional, and identifying new entities. In 2022, two different models were proposed to classify hematolymphoid neoplasms: the 5th edition of the WHO classification (WHO-HAEM5) and the International Consensus Classification (ICC). Of note, a common nosography is mandatory to ensure progress in health science and ensure the basis for a real precision medicine. In this article, the authors summarized the main differences with the previous fourth WHO edition and reviewed the main discrepancies between the two newest classifications, as far as PTCLs are concerned.
外周 T 细胞淋巴瘤(PTCLs)是一种罕见的非霍奇金淋巴瘤亚型,由于其罕见性和生物学复杂性,在诊断和分类方面常常存在很大的困难。2001 年、2008 年和 2017 年世界卫生组织(WHO)造血肿瘤分类的前几个版本旨在普遍标准化造血肿瘤的诊断。自那时以来,在淋巴瘤领域取得了关键的临床病理、免疫表型和最近的分子发现,有助于完善几种疾病的诊断标准,提升以前定义为临时的实体,并确定新的实体。2022 年,提出了两种不同的模型来对血液淋巴肿瘤进行分类:第五版世界卫生组织分类(WHO-HAEM5)和国际共识分类(ICC)。值得注意的是,为了确保健康科学的进步并为真正的精准医学奠定基础,强制性采用通用的分类学是必要的。本文作者总结了与前一版第四版 WHO 分类的主要区别,并就 PTCLs 而言,回顾了两个最新分类之间的主要差异。